When combined with your clinical history and provider evaluation, this information can guide conversations about formulation selection, dosing strategy, and anticipated adaptation timelines
Cardiovascular Benefits : Semaglutide has been shown to have benefits for heart health
This paper supports the importance of resistance training and protein intake during GLP-1 therapy, suggesting that body composition improvements depend on structured lifestyle support
He has received research support from Eli Lilly, Boehringer Ingelheim, MSD, Novo Nordisk, Novartis and Sanofi
Kavita Sharma, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues used data from 1,145 participants in a multisite, international trial, in which participants with obesity-related HFpEF were randomly assigned (1:1) to once-weekly semaglutide (2.4 mg) or placebo for 52 weeks
Exercise to maintain bone and muscle strength